Leaderboards/Advances in Oncology and Radiotherapy

Advances in Oncology and Radiotherapy

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Zachary J. Ward
Harvard University
2
The Lancet Oncology
Unknown
3
Meegan Shepherd
Royal North Shore Hospital
4
Elizabeth Gourd
Unknown
5
C. Shelley
Royal Surrey County Hospital
6
Priyamvada Maitre
Homi Bhabha National Institute
7
Ghulam Farid
Shalamar Hospital
8
Paige L. Myers
University of Michigan
9
Katie Langin
Kleijnen Systematic Reviews (United Kingdom)
10
Shadi Ahmadmehrabi
University of Pennsylvania

Rising Stars Papers

1
Global maternal mortality projections by urban/rural location and education level: a simulation-based analysis
EClinicalMedicine|2024
22 cit.
2
Cancer incidence and survival for 11 cancers in the Commonwealth: a simulation-based modelling study
The Lancet Oncology|2024
17 cit.
3
Late Urinary Toxicity and Quality of Life With Pelvic Radiation Therapy for High-Risk Prostate Cancer: Dose-Effect Relations in the POP-RT Randomized Phase 3 Trial
International Journal of Radiation Oncology*Biology*Physics|2024
13 cit.
4
Training for tomorrow: Establishing a worldwide curriculum in online adaptive radiation therapy
Technical Innovations & Patient Support in Radiation Oncology|2025
6 cit.
5
Investing in cancer care in the UK: why aren't we acting on the evidence?
The Lancet Oncology|2024
5 cit.
6
Association of continuous BMI with health‐related quality of life in the United States by age and sex
Obesity|2024
4 cit.
7
Comparing Wise Pattern to Non–Wise Pattern Skin-Sparing Mastectomy: A Critical Evaluation of Patient Demographics and Surgical Outcomes
Plastic & Reconstructive Surgery|2024
3 cit.
8
Jordan joins the Global Platform for Access to Childhood Cancer Medicines
The Lancet Oncology|2024
3 cit.
9
Global maternal health country typologies: A framework to guide policy
PLOS Global Public Health|2024
3 cit.
10
Microsurgeon Development, Attrition, and Hope for the Future: A Qualitative Analysis
Journal of Reconstructive Microsurgery|2024
3 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
mustafa Başturk
Unknown
2
Rachel Abudu
Frederick National Laboratory for Cancer Research
3
Doug H.M. Pyle
American Society of Clinical Oncology
4
Praveen Vikas
University of Iowa
5
André Ilbawi
World Health Organization
6
Jing Yang
Guilin Medical University
7
Hina Saeed
Iqra University
8
Patricia A. Sharpnack
Ursuline College
9
Rajarshi Sengupta
American Association For Cancer Research
10
Harjyot Toor
Kaiser Permanente Fontana Medical Center

Emerging Leaders Papers

1
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline
Journal of Clinical Oncology|2023
110 cit.
2
<i>AACR Cancer Disparities Progress Report 2022</i>
Cancer Epidemiology Biomarkers & Prevention|2022
87 cit.
3
Prevalence of Central Line-Associated Bloodstream Infections (CLABSI) in Intensive Care and Medical-Surgical Units
Cureus|2022
40 cit.
4
AACR Cancer Disparities Progress Report 2024: Achieving the Bold Vision of Health Equity
Cancer Epidemiology Biomarkers & Prevention|2024
34 cit.
5
Developing and sustaining high-quality care for children with cancer: the WHO Global Initiative for Childhood Cancer
Revista Panamericana de Salud Pública|2023
29 cit.
6
AACR Cancer Progress Report 2023: Advancing the Frontiers of Cancer Science and Medicine
Clinical Cancer Research|2023
25 cit.
7
<i>AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care</i>
Clinical Cancer Research|2022
23 cit.
8
<i>AACR Cancer Progress Report 2022:</i> Decoding Cancer Complexity, Integrating Science, and Transforming Patient Outcomes
Clinical Cancer Research|2022
20 cit.
9
Made Better by Chat GPT: Cultivating a Culture of Innovation in Nursing Education
Nursing Education Perspectives|2024
16 cit.
10
Use of Immune Checkpoint Inhibitors in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A
JCO Oncology Practice|2022
9 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
John A. H. Waterhouse
Wesley Hospital
2
Michael Bartoň
Ikerbasque
3
Ellen Yorke
Memorial Sloan Kettering Cancer Center
4
Umberto Veronesi
Fondazione IRCCS Istituto Nazionale dei Tumori
5
Christopher Lewis
Dartmouth College
6
Yolande Lievens
Ghent University Hospital
7
William Harnett
University of Strathclyde
8
Cai Grau
Aarhus University Hospital
9
Salman Khan
Quaid-i-Azam University
10
Donald Maxwell Parkin
University of Oxford

Current Senior Leaders Papers

1
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
International Journal of Cancer|2010
21.4k cit.
2
Global Cancer Statistics, 2002
CA A Cancer Journal for Clinicians|2005
18.4k cit.
3
Cancer Incidence in Five Continents
Unknown Journal|1970
8.5k cit.
4
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
The Lancet|2018
6.2k cit.
5
Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer
New England Journal of Medicine|2002
4.4k cit.
6
Global cancer statistics
CA A Cancer Journal for Clinicians|1999
3.4k cit.
7
The global health burden of infection‐associated cancers in the year 2002
International Journal of Cancer|2006
2.9k cit.
8
The management of respiratory motion in radiation oncology report of AAPM Task Group 76a)
Medical Physics|2006
2.3k cit.
9
A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer
New England Journal of Medicine|2003
2.2k cit.
10
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
The Lancet|1997
1.9k cit.

Reagents for Advances in Oncology and Radiotherapy

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 64

CD79B (D5K3Q) Rabbit Monoclonal Antibody (BSA and Azide Free)

#71713$865
View Evidence →
Cell Signaling TechnologyEvidence 62

TPBG/5T4 (E4T8Q) Rabbit Monoclonal Antibody

#30874$194,431
View Evidence →
Cell Signaling TechnologyEvidence 65

Phospho-PZR (Tyr263) Antibody

#5543$362
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 65

LPCAT1 (E4V4B) Rabbit Monoclonal Antibody

Cited in 10 papers
#57411$168,369
View Evidence →
Cell Signaling TechnologyEvidence 70

cGAS (E5V3W) Rabbit Monoclonal Antibody (BSA and Azide Free)

#86793$865
View Evidence →
Cell Signaling TechnologyEvidence 66

VGLUT2 (D7D2H) Rabbit Monoclonal Antibody

#71555$161,351
View Evidence →